Acamprosate in the treatment of binge eating disorder: A placebo-controlled trial

International Journal of Eating Disorders

Volumn 44, Issue 1, 2011, Pages 81-90

  McElroy, Susan L ^a,b   Guerdjikova, Anna I ^a,b   Winstanley, Erin L ^a,b   O'Melia, Anne M ^a,b   Mori, Nicole ^a,b   McCoy, Jessica ^a,b   Keck Jr , Paul E ^a,b   Hudson, James I ^c  

^a Research Institute   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

acamprosate; binge eating disorder; glutamate; obesity

Indexed keywords

ACAMPROSATE; PLACEBO;

ADULT; ARTICLE; BINGE EATING DISORDER; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT RESPONSE;

ADULT; BINGE-EATING DISORDER; BODY MASS INDEX; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TAURINE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 78650265278     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20876     Document Type: Article

References (59)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association, 2000.
2. Peterson CB, Miller KB, Crow SJ, Thuras P, Mitchell JE,. Subtypes of binge eating disorder based on psychiatric history. Int J Eat Disord 2005; 38: 273-276. (Pubitemid 41618969)
3. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC,. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61: 348-358. (Pubitemid 46108682)
4. Wonderlich SA, Gordon KH, Mitchell JE, Crosby RD, Engel SG,. The validity and clinical utility of binge eating disorder. Int J Eat Disord 2009; 42: 687-705.
5. Yager J,. Binge eating disorder: The search for better treatments. Am J Psychiatry 2008; 165: 4-6. (Pubitemid 351704542)
6. Brownley KA, Berkman ND, Sedway JA, Lohr KN, Bulik CM,. Binge eating disorder treatment: A systematic review of randomized controlled trials. Int J Eat Disord 2007; 40: 337-348. (Pubitemid 46651308)
7. Reas DL, Grilo CM,. Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring) 2008; 16: 2024-2038.
8. Stefano SC, Bacaltchuk J, Blay SL, Appolinario JC,. Antidepressants in short-term treatment of binge eating disorder: Systematic review and meta-analysis. Eat Behav 2008; 9: 129-136. (Pubitemid 351325722)
9. Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 2003; 60: 1109-1116. (Pubitemid 37429650)
10. Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, et al. Efficacy of sibutramine for the treatment of binge eating disorder: A randomized multicenter placebo-controlled double-blind study. Am J Psychiatry 2008; 165: 51-58. (Pubitemid 351704552)
11. McElroy SL, Arnold LM, Shapira NA, Keck PE Jr, Rosenthal NR, Karim MR, et al. Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. Am J Psychiatry 2003; 160: 255-261.
12. McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR,. Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Biol Psychiatry 2007; 61: 1039-1048. (Pubitemid 46551975)
13. Claudino AM, de Oliveira IR, Appolinario JC, Cordas TA, Duchesne M, Sichieri R, et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry 2007; 68: 1324-1332. (Pubitemid 47524510)
14. McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, et al. Zonisamide in the treatment of binge eating disorder with obesity: A randomized controlled trial. J Clin Psychiatry 2006; 67: 1897-1906. (Pubitemid 46055195)
15. McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, et al. Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. J Clin Psychiatry 2007; 68: 390-398. (Pubitemid 46506803)
16. Grilo CM, Masheb RM, Salant SL,. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial. Biol Psychiatry 2005; 57: 1193-1201. (Pubitemid 40615782)
17. Golay A, Laurent-Jaccard A, Habicht F, Gachoud JP, Chabloz M, Kammer A, et al. Effect of orlistat in obese patients with binge eating disorder. Obes Res 2005; 13: 1701-1708.
18. Mann K, Lehert P, Morgan MY,. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcohol Clin Exp Res 2004; 28: 51-63. (Pubitemid 38114023)
19. Mann K, Kiefer F, Spanagel R, Littleton J,. Acamprosate: Recent findings and future research directions. Alcohol Clin Exp Res 2008; 32: 1105-1110.
20. Avena NM,. Examining the addictive-like properties of binge eating using an animal model of sugar dependence. Exp Clin Psychopharmacol 2007; 15: 481-491.
21. Davis C, Carter JC,. Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite 2009; 53: 1-8.
22. Root TL, Pisetsky EM, Thornton L, Lichtenstein P, Pedersen NL, Bulik CM,. Patterns of co-morbidity of eating disorders and substance use in Swedish females. Psychol Med 2010; 40: 105-115.
23. Calero-Elvira A, Krug I, Davis K, Lopez C, Fernandez-Aranda F, Treasure J,. Meta-analysis on drugs in people with eating disorders. Eur Eat Disord Rev 2009; 17: 243-259.
24. Stanley BG, Willett VL III, Donias HW, Dee MG II, Duva MA,. Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control. Am J Physiol 1996; 270: R443-R449. (Pubitemid 126756307)
25. Meister B,. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 2007; 92: 263-271. (Pubitemid 47374238)
26. Gass JT, Olive MF,. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 2008; 75: 218-265.
27. Kalivas PW, Lalumiere RT, Knackstedt L, Shen H,. Glutamate transmission in addiction. Neuropharmacology 2009; 56 (Suppl 1): 169-173.
28. Han DH, Lyool IK, Sung YH, Lee SH, Renshaw PF,. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence. Drug Alcohol Depend 2008; 93: 279-283.
29. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, et al. Oral topiramate for treatment of alcohol dependence: A randomized controlled trial. Lancet 2003; 361: 1677-1685. (Pubitemid 36577440)
30. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, et al. Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA 2007; 298: 1641-1651. (Pubitemid 47606653)
31. Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: Improvement in binge and purge measures. J Clin Psychiatry 2003; 64: 1335-1341. (Pubitemid 37490239)
32. Bisaga A, Danysz W, Foltin RW,. Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. Eur Neuropsychopharmacol 2008; 18: 794-802.
33. Hermanussen M, Tresguerres JA,. A new anti-obesity drug treatment: First clinical evidence that,antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders. Econ Hum Biol 2005; 3: 329-337. (Pubitemid 40984134)
34. Brennan BP, Roberts JL, Fogarty KV, Reynolds KA, Jonas JM, Hudson JI,. Memantine in the treatment of binge eating disorder: An open-label, prospective trial. Int J Eat Disord 2008; 41: 520-526.
35. Blednov YA, Adron Harris R,. Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: Relationship to acamprosate actions. Int J Neuropsychopharmacol 2008; 11: 775-793.
36. O'Brien CP,. Anticraving medications for relapse prevention: A possible new class of psychoactive medications. Am J Psychiatry 2005; 162: 1423-1431.
37. Marrazzi MA, Bacon JP, Kinzie J, Luby ED,. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995; 10: 163-172.
38. Marrazzi MA, Markham KM, Kinzie J, Luby ED,. Binge eating disorder: Response to naltrexone. Int J Obes Relat Metab Disord 1995; 19: 143-145.
39. Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, et al. Treatment of bulimia with bupropion: A multicenter controlled trial. J Clin Psychiatry 1988; 49: 262-266.
40. First MB, Spitzer RL, Gibbon M, Williams JBW,. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute, 2002.
41. Reas DL, Grilo CM, Masheb RM,. Reliability of the eating disorder examination-questionnaire in patients with binge eating disorder. Behav Res Ther 2006; 44: 43-51. (Pubitemid 41654480)
42. Guy W,. ECDEU Assessment Manual for Psychopharmacology, US Department of Health, Education, and Welfare publication (ADM). Rockville, MD: National Institute of Mental Health, 1976.
43. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The yale-brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
44. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG,. Development and validation of the food-craving inventory. Obes Res 2002; 10: 107-114.
45. Stunkard A, Messick S,. Eating Inventory Manual. San Antonio: The Psychological Corporation,Harcourt Brace and Company, 1988.
46. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
47. Ware J Jr, Kosinski M, Keller SD,. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233. (Pubitemid 126433231)
48. White MA, Grilo CM,. Psychometric properties of the food craving inventory among obese patients with binge eating disorder. Eat Behav 2005; 6: 239-245.
49. Fitzmaurice GM, Laird NM, Ware JH,. Applied Longitudinal Analysis. Hoboken,NJ: Wiley, 2004.
50. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of depression collaborative research program dataset. Arch Gen Psychiatry 1993; 50: 739-750. (Pubitemid 23263811)
51. Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE Jr, Carter WP, et al. Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998; 155: 1756-1762. (Pubitemid 28547503)
52. McElroy SL, Casuto LS, Nelson EB, Lake KA, Soutullo CA, Keck PE Jr, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000; 157: 1004-1006.
53. Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE,. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 2002; 63: 1028-1033. (Pubitemid 35388063)
54. McElroy SL, Hudson JI, Malhotra S, Welge JA, Nelson EB, Keck PE Jr,. Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial. J Clin Psychiatry 2003; 64: 807-813. (Pubitemid 36897217)
55. Guerdjikova AI, McElroy SL, Kotwal R, Welge JA, Nelson E, Lake K, et al. High-dose escitalopram in the treatment of binge-eating disorder with obesity: A placebo-controlled monotherapy trial. Hum Psychopharmacol 2008; 23: 1-11. (Pubitemid 351166063)
56. Gendall KA, Joyce PR, Sullivan PF, Bulik CM,. Food cravers: Characteristics of those who binge. Int J Eat Disord 1998; 23: 353-360.
57. Sobik L, Hutchison K, Craighead L,. Cue-elicited craving for food: A fresh approach to the study of binge eating. Appetite 2005; 44: 253-261. (Pubitemid 40775749)
58. Greeno CG, Wing RR, Shiffman S,. Binge antecedents in obese women with and without binge eating disorder. J Consult Clin Psychol 2000; 68: 95-102. (Pubitemid 30120954)
59. Moreno S, Warren CS, Rodriguez S, Fernandez MC, Cepeda-Benito A,. Food cravings discriminate between anorexia and bulimia nervosa. Implications for "success" versus "failure" in dietary restriction. Appetite 2009; 52: 588-594.